# Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

> **NCT02340169** · PHASE4 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 129 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** Topicort® (desoximetasone) Topical Spray, 0.25%

## Key facts

- **NCT ID:** NCT02340169
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-23
- **Primary completion:** 2019-11-22
- **Final completion:** 2021-11-22
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02340169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02340169, "Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02340169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*